Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May;38(5):887-893.
doi: 10.1007/s00296-018-4002-8. Epub 2018 Mar 2.

Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders

Affiliations

Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders

Mikhail M Kostik et al. Rheumatol Int. 2018 May.

Abstract

NLRP12-related autoinflammatory disease (NLRP12-AID) is an exceptionally rare autosomal dominant disorder caused by germline mutations in NLRP12 gene. Very few patients with NLRP12-AD have been identified worldwide; therefore, there is a scarcity of data on phenotypic presentation of this syndrome. Here we provide evidence that NLRP12-AID may have clinical manifestations characteristic for primary immune deficiencies (PID). 246 children with periodic fever (PF) of unknown origin were subjects to the next generation sequencing (NGS) analysis; 213 of these patients had signs of primary immunodeficiency (PID) manifested by recurrent infections, while 33 kids had isolated PF. The NGS panel was composed of 302 genes implicated in PID and/or AID. 15 patients (9 girls and 6 boys) with NLRP12-AID were identified. Median age of first AID-related fever episode was 12 months, ranging from 2 months to 13 years. Main clinical features of NLRP12-related AID were periodic fever (100%), abdominal pain and diarrhea (47%), arthralgia (20%), headache (20%) and failure to thrive (33%). Nine patients demonstrated increased susceptibility to infection and two children suffered from Crohn's disease. Administration of short courses of NSAID or corticosteroids resulted in resolution of the disease flare. In one severe case, canakinumab (anti-interleukin-1β antibody) was successfully used. Significant number of patients with genetically assigned diagnosis of NLPR12-AID has clinical features which close resemble primary immune deficiency. This phenotypic overlap may result in underdiagnosis of NLPR12-AID among patients with PID.

Keywords: Familial cold autoinflammatory syndrome; NLRP12-autoinflammatory disease; Periodic fever.

PubMed Disclaimer

References

    1. J Clin Immunol. 2016 May;36 Suppl 1:68-75 - PubMed
    1. Immunity. 2012 May 25;36(5):742-54 - PubMed
    1. J Biol Chem. 2005 Dec 2;280(48):39914-24 - PubMed
    1. Nat Immunol. 2017 May;18(5):541-551 - PubMed
    1. Oncotarget. 2016 May 24;7(21):30575-84 - PubMed

MeSH terms

Substances

LinkOut - more resources